| Quarter (USD) | Sep 24 | Dec 23 | Sep 23 | Jun 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 237.19 mm | 237.19 mm | 237.19 mm | 237.19 mm | 237.19 mm | 237.19 mm |
| Cash burn (monthly) | 54.63 mm | 9.91 mm | 36.71 mm | 20.68 mm | (no burn) | 22.03 mm |
| Cash used (since last report) | 152.16 mm | 27.61 mm | 102.25 mm | 57.61 mm | n/a | 61.37 mm |
| Cash remaining | 85.03 mm | 209.58 mm | 134.94 mm | 179.58 mm | n/a | 175.82 mm |
| Runway (months of cash) | 1.6 | 21.1 | 3.7 | 8.7 | n/a | 8.0 |
| 13F holders | Current |
|---|---|
| Total holders | 410 |
| Opened positions | 42 |
| Closed positions | 85 |
| Increased positions | 126 |
| Reduced positions | 126 |
| 13F shares | Current |
|---|---|
| Total value | 2.54 tn |
| Total shares | 74.35 mm |
| Total puts | 1.90 mm |
| Total calls | 1.10 mm |
| Total put/call ratio | 1.7 |
| Largest owners | Shares | Value |
|---|---|---|
| Capital International Investors | 7.93 mm | $372.40 bn |
| ARK Investment Management | 7.50 mm | $352.29 bn |
| VRTX Vertex Pharmaceuticals | 5.38 mm | $353.37 mm |
| GSK GSK | 3.31 mm | $278.46 mm |
| STT State Street | 2.99 mm | $140.61 bn |
| CMTDF Sumitomo Mitsui Trust | 2.97 mm | $139.44 bn |
| Nikko Asset Management Americas | 2.97 mm | $139.37 bn |
| Bayer Global Investments B.V. | 2.95 mm | $154.89 mm |
| BLK BlackRock | 2.80 mm | $131.32 bn |
| T. Rowe Price Investment Management | 2.74 mm | $128.61 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 2 Dec 24 | Samarth Kulkarni | Common Shares | Sell | Dispose S | No | Yes | 55.1043 | 15,000 | 826.56 k | 181,540 |
| 11 Nov 24 | Samarth Kulkarni | Common Shares | Sell | Dispose S | No | Yes | 56.27 | 6,879 | 387.08 k | 196,540 |
| 11 Nov 24 | Samarth Kulkarni | Common Shares | Sell | Dispose S | No | Yes | 55.43 | 23,121 | 1.28 mm | 203,419 |
| 16 Oct 24 | Kasinger James R. | RSU Common Shares | Grant | Acquire A | No | No | 0 | 30,000 | 0.00 | 30,000 |
| 16 Oct 24 | Kasinger James R. | Stock Option Common Shares | Grant | Acquire A | No | No | 49 | 18,333 | 898.32 k | 18,333 |
| 16 Oct 24 | Julianne Bruno | Stock Option Common Shares | Grant | Acquire A | No | No | 49 | 18,333 | 898.32 k | 18,333 |
| 16 Oct 24 | Samarth Kulkarni | RSU Common Shares | Grant | Acquire A | No | No | 0 | 400,000 | 0.00 | 400,000 |
| 16 Oct 24 | Samarth Kulkarni | Stock Option Common Shares | Grant | Acquire A | No | No | 49 | 55,000 | 2.70 mm | 55,000 |
